Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies
- 1 July 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (6) , 1847-1849
- https://doi.org/10.1016/j.transproceed.2004.07.021
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assayTransplantation Proceedings, 2001
- New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant RecipientsClinical Microbiology Reviews, 2000
- Prevention and treatment of cytomegalovirus infection in organ transplant recipientsTransplant Infectious Disease, 1999
- Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant RecipientsAnnals of Internal Medicine, 1995
- Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.The Journal of Experimental Medicine, 1994
- Symptomatic Cytomegalovirus Infection in Renal Transplant Recipients Given Either Minnesota Antilymphoblast Globulin (MALG) or OKT3 for Rejection ProphylaxisAmerican Journal of Kidney Diseases, 1993
- Management and Prevention of Cytomegalovirus Infection After Renal TransplantationMayo Clinic Proceedings, 1992
- Epidemiology of Cytomegalovirus InfectionsClinical Infectious Diseases, 1990
- Infections with Cytomegalovirus and Other Herpesviruses in 121 Liver Transplant Recipients: Transmission by Donated Organ and the Effect of OKT3 AntibodiesThe Journal of Infectious Diseases, 1988